Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States.
Pacira Biosciences stock last closed at $26.10, down 2.5% from the previous day, and has decreased 39.96% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.28 percentage points. Pacira Biosciences stock is currently +1.32% from its 52-week low of $25.76, and -46.3% from its 52-week high of $48.60.
There are currently 46.5M PCRX shares outstanding. The market capitalization of PCRX is $1.21B. In the past 24 hours, 619,666 PCRX shares were traded.
How to Buy Pacira Biosciences Stock
Not sure how to invest in Pacira Biosciences stock? Here's how.
Figure out where to buy Pacira Biosciences stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Pacira Biosciences stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Pick your payment method and add your information.
Analyze Pacira Biosciences stock: The Pacira Biosciences ticker symbol is PCRX. Is Pacira Biosciences stock a good investment? Should you buy shares of PCRX? How do PCRX's underlying business fundamentals look? Do top analysts think Pacira Biosciences is a good buy? Why has PCRX's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if PCRX is a good stock to buy).
Execute your PCRX buy order: Decide if you will purchase PCRX shares at the current market price or use a limit order to buy PCRX stock at a given price.
Monitor your PCRX position: Create a watchlist to important updates regarding your investment in Pacira Biosciences shares.
Step 1: Figure out where to buy Pacira Biosciences stock
You need an online brokerage account to access the NASDAQ market and buy PCRX stock.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world financial markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal info so you can invest in PCRX stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Pacira Biosciences stock
Once you have chosen the best place to buy Pacira Biosciences stock, it's crucial to analyze their stock prior to buying, so you can wrap your head around the risk and opportunity.
Pacira Biosciences shares data
PCRX Price
$26.10
1w %
-4.61%
1y %
-39.96%
5y %
-29.1%
P/E
28.68x
P/B
1.39x
P/S
1.79x
PEG
0.32x
Revenue
$674.98M
Earnings
$41.96M
Fore. Rev. Growth
7.45%
Fore. Earn. Growth
90.49%
Market Cap
$1.21B
Next Earnings
May 1, 2024
Next Dividend
N/A
Pacira Biosciences Due Diligence Checks
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.
There are more short-term assets than short-term liabilities on the PCRX balance sheet.
Total PCRX debt is lower than 5 years ago, relative to shareholder equity.
PCRX profit margin has gone up from 2.4% to 6.2% in the past year.
PCRX's operating cash flow of $154.65M allows it to safely service it's debt of $586.04M.
Failed Financial Due Diligence Checks:
PCRX earnings of $82.01M is not sufficient to cover its interest payments.
There are more long-term liabilities than short-term assets on the PCRX balance sheet.
PCRX has a relatively high debt to equity ratio of 0.81.
Is it a good time to buy Pacira Biosciences stock, according to Wall Street analysts?
Out of 8 Wall Street analysts who monitor PCRX, the consensus analyst rating on PCRX is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
Latest PCRX Analyst Forecasts
Gary Nachman, a bottom 12% analyst from Raymond James initiates coverage on PCRX with a buy rating and announces their PCRX price target of $42.00, on Dec 20, 2023.
David Amsellem, a top 26% analyst from Piper Sandler maintains PCRX with a strong buy rating and lowers their PCRX price target from $50.00 to $42.00, on Nov 3, 2023.
Balaji Prasad, a bottom 7% analyst from Barclays maintains PCRX with a strong buy rating and lowers their PCRX price target from $60.00 to $57.00, on Oct 23, 2023.
Last year, PCRX earnings were $41.96M. In the past 3 year, PCRX's earnings have gone up by -90.17% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of -10.04%.
Last year, PCRX revenue was $674.98M. Over the last five year, PCRX's revenue has grown by 14.88% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.7%.
No, Pacira Biosciences doesn't provide an income stream by paying out dividends.
What others are saying about PCRX
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your PCRX buy order
You have two main options:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually fine for most investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at a specific dollar amount, use a limit order.
Hit the Open Trade button and your broker will place your order.
If you want more help buying stocks on eToro, click the how to video below:
How much does it cost to buy one Pacira Biosciences share?
As of Apr 18, 2024, it costs $26.10 to buy one share of Pacira Biosciences stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.383 shares of PCRX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.